NO953367L - Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler - Google Patents
Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidlerInfo
- Publication number
- NO953367L NO953367L NO953367A NO953367A NO953367L NO 953367 L NO953367 L NO 953367L NO 953367 A NO953367 A NO 953367A NO 953367 A NO953367 A NO 953367A NO 953367 L NO953367 L NO 953367L
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- phenyl
- amino
- substituted
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4430638A DE4430638A1 (de) | 1994-08-29 | 1994-08-29 | Verwendung von substituierten 4-Phenyl-6-amino-nicotinsäurederivaten als Arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953367D0 NO953367D0 (no) | 1995-08-28 |
| NO953367L true NO953367L (no) | 1996-03-01 |
| NO308287B1 NO308287B1 (no) | 2000-08-28 |
Family
ID=6526833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953367A NO308287B1 (no) | 1994-08-29 | 1995-08-28 | Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5670525A (no) |
| EP (1) | EP0705820A1 (no) |
| JP (1) | JPH0867670A (no) |
| KR (1) | KR960007565A (no) |
| CN (1) | CN1127114A (no) |
| AU (1) | AU697552B2 (no) |
| CA (1) | CA2156961A1 (no) |
| CZ (1) | CZ219895A3 (no) |
| DE (1) | DE4430638A1 (no) |
| EE (1) | EE9500059A (no) |
| FI (1) | FI954007A (no) |
| HU (1) | HUT74618A (no) |
| IL (1) | IL115072A (no) |
| NO (1) | NO308287B1 (no) |
| NZ (1) | NZ272851A (no) |
| PL (1) | PL310145A1 (no) |
| RU (1) | RU2154635C2 (no) |
| SK (1) | SK106595A3 (no) |
| TW (1) | TW419464B (no) |
| ZA (1) | ZA957187B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001523002A (ja) * | 1997-11-10 | 2001-11-20 | ブリストル−マイヤーズ スクイブ カンパニー | アルツハイマー病の診断方法 |
| DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10060807A1 (de) * | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10110747A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
| DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
| US7671065B2 (en) * | 2005-02-24 | 2010-03-02 | Janssen Pharmaceutica N.V. | Pyridine derivatives as potassium ion channel openers |
| DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
| DE102006056740A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
| DE102006056739A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
| DE102007035367A1 (de) * | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
| DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
| DE102007061764A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
| DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
| DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
| JP2011520997A (ja) * | 2008-05-29 | 2011-07-21 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | ２−アルコキシ置換ジシアノピリジン類およびそれらの使用 |
| DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
| DE102009006602A1 (de) * | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
| DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
| US20120058983A1 (en) | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| KR20130056345A (ko) * | 2010-09-17 | 2013-05-29 | 퍼듀 퍼머 엘피 | 피리딘 화합물 및 그의 용도 |
-
1994
- 1994-08-29 DE DE4430638A patent/DE4430638A1/de not_active Withdrawn
-
1995
- 1995-07-20 TW TW084107499A patent/TW419464B/zh active
- 1995-08-16 EP EP95112833A patent/EP0705820A1/de not_active Withdrawn
- 1995-08-22 US US08/517,873 patent/US5670525A/en not_active Expired - Fee Related
- 1995-08-23 PL PL95310145A patent/PL310145A1/xx unknown
- 1995-08-23 AU AU30205/95A patent/AU697552B2/en not_active Ceased
- 1995-08-24 JP JP7237915A patent/JPH0867670A/ja active Pending
- 1995-08-25 IL IL11507295A patent/IL115072A/xx not_active IP Right Cessation
- 1995-08-25 NZ NZ272851A patent/NZ272851A/en unknown
- 1995-08-25 CA CA002156961A patent/CA2156961A1/en not_active Abandoned
- 1995-08-25 FI FI954007A patent/FI954007A/fi unknown
- 1995-08-25 CN CN95116625A patent/CN1127114A/zh active Pending
- 1995-08-28 EE EE9500059A patent/EE9500059A/xx unknown
- 1995-08-28 ZA ZA957187A patent/ZA957187B/xx unknown
- 1995-08-28 KR KR1019950026840A patent/KR960007565A/ko not_active Application Discontinuation
- 1995-08-28 RU RU95114449/04A patent/RU2154635C2/ru active
- 1995-08-28 HU HU9502520A patent/HUT74618A/hu unknown
- 1995-08-28 SK SK1065-95A patent/SK106595A3/sk unknown
- 1995-08-28 NO NO953367A patent/NO308287B1/no not_active IP Right Cessation
- 1995-08-28 CZ CZ952198A patent/CZ219895A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU697552B2 (en) | 1998-10-08 |
| DE4430638A1 (de) | 1996-03-07 |
| HU9502520D0 (en) | 1995-10-30 |
| CA2156961A1 (en) | 1996-03-01 |
| TW419464B (en) | 2001-01-21 |
| NZ272851A (en) | 1997-07-27 |
| ZA957187B (en) | 1996-04-17 |
| FI954007A (fi) | 1996-03-01 |
| FI954007A0 (fi) | 1995-08-25 |
| EE9500059A (et) | 1996-04-15 |
| PL310145A1 (en) | 1996-03-04 |
| HUT74618A (en) | 1997-01-28 |
| IL115072A (en) | 1999-12-31 |
| JPH0867670A (ja) | 1996-03-12 |
| CZ219895A3 (en) | 1996-03-13 |
| NO308287B1 (no) | 2000-08-28 |
| SK106595A3 (en) | 1997-01-08 |
| AU3020595A (en) | 1996-03-14 |
| KR960007565A (ko) | 1996-03-22 |
| US5670525A (en) | 1997-09-23 |
| IL115072A0 (en) | 1995-12-08 |
| NO953367D0 (no) | 1995-08-28 |
| EP0705820A1 (de) | 1996-04-10 |
| RU2154635C2 (ru) | 2000-08-20 |
| CN1127114A (zh) | 1996-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953367L (no) | Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler | |
| BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
| DE19681287T1 (de) | Orale Formulierung von 2-Methylthienobenzodiazepin | |
| ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
| AR027162A1 (es) | Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen | |
| NO984878D0 (no) | Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere | |
| NO973938D0 (no) | Farmasöytisk preparat av piperdinoalkanolforbindelser | |
| FI944800A (fi) | Indoli-2-karboksyylihappojohdannaisia | |
| NO20040145L (no) | Anvendelse av benzensulfonamidderivater for fremstilling av et medikament | |
| NO20002443L (no) | FremgangsmÕte for fremstilling av derivater av taxoidklassen | |
| ATE255117T1 (de) | Aminophosphonsäure-derivate als arzneimittel | |
| AR016694A1 (es) | Procedimiento para la preparacion de derivados de acidos 8-metoxi-3-quinoloncarboxilicos y procedimiento de purificacion. | |
| NO991613L (no) | Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering | |
| NO982754L (no) | Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter | |
| FI973124A0 (fi) | D-vitamiinijohdannaisten dermatologinen käyttö | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| NO995388D0 (no) | Fremgangsmåte for fremstilling av formylfosfonsyre | |
| DK0876367T3 (da) | Trans apovincaminsyreesterderivater som lægemidler | |
| DE69527684D1 (de) | Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten | |
| NO924763L (no) | Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| DE69502982D1 (de) | Herstellung geschützter Aminothiazolylessigsäurederivate | |
| NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater | |
| NO961429D0 (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
| NO940131D0 (no) | Salter av 4-pyrimidinon-derivater for framasoeytisk anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN FEBRUARY 2002 |